baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JP Morgan Call 275 AMGN 17.05.202.../ DE000JK2GFA8 /

2024-04-30 11:17:03 AM	Chg.-	Bid10:02:18 AM	Ask10:02:18 AM	Underlying	Strike price	Expiration date	Option type
0.800EUR	-	0.870 Bid Size: 5,000	0.890 Ask Size: 5,000	Amgen Inc	275.00 USD	2024-05-17	Call

GlobeNewswire 05-01 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...

GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

GlobeNewswire 04-30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...

GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...

TeleTrader 04-24 Wall Street opens mostly higher amid earnings jitters

GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...

GlobeNewswire 04-16 Turnstone Biologics Appoints William Waddill to its Board of Directors

GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

GlobeNewswire 04-15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

GlobeNewswire 04-15 Shah Capital nominates two highly qualified independent director candidates for Novavax

GlobeNewswire 04-11 FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer

GlobeNewswire 04-09 Opthea Appoints John Han, PharmD, as VP Medical Affairs

GlobeNewswire 04-08 Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual ...

GlobeNewswire 04-08 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...

GlobeNewswire 04-05 NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US

GlobeNewswire 04-05 CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US

GlobeNewswire 04-05 NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US

GlobeNewswire 04-04 Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth

GlobeNewswire 04-03 CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engag...

GlobeNewswire 04-02 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer

GlobeNewswire 03-28 Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

TeleTrader 03-26 US opens higher on data, Trump Media launch

GlobeNewswire 03-25 Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...

GlobeNewswire 03-25 Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Director...

GlobeNewswire 03-21 CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

JP Morgan Call 275 AMGN 17.05.202.../ DE000JK2GFA8 /

If you wish to receive reply to your feedback, please provide your email address.